Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients.
Pietro Quaglino(Department of Medical Sciences), Maria Grazia Bernengo(University of Turin), Mario Boccadoro(University of Turin), Tiziana Nardò(University of Turin), Maria Teresa Fierro(University of Turin), Paola Savoia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Umberto Vitolo(Candiolo Cancer Institute), Lorella Orsucci(Azienda Ospedaliero Universitaria San Giovanni Battista), Paolo Fava, Federica Marenco(University Dermatology), E. Marra, Massimo Massaia(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
PubMed
October 1, 2013
Cited by 7
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
|Leukemia|2008|808
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
|Leukemia|2011|721
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657